Europe Radiotherapy Market
시장 규모 (USD 10억)
연평균 성장률 :
% 
 예측 기간 |
2023 –2030 |
 시장 규모(기준 연도) |
USD 2,176.99 Million |
 시장 규모(예측 연도) |
USD 3,890.91 Million |
 연평균 성장률 |
% |
| 주요 시장 플레이어 |
|
>유럽 방사선 치료 시장, 제품 및 서비스별(서비스, 제품 및 소프트웨어), 유형(외부 빔 방사선 치료, 내부 방사선 치료, 전신 방사선 치료/ 방사성 의약품 및 기타), 응용 분야(유방암, 폐암, 전립선암, 대장암, 림프종, 간암, 갑상선암, 뇌암, 자궁경부암, 척추암 및 기타), 최종 사용자(병원, 방사선 치료 센터, 전문 클리닉 및 기타), 유통 채널(직접 입찰, 제3자 유통업체 및 기타) - 업계 동향 및 2030년까지의 예측.
유럽 방사선 치료 시장 분석 및 규모
유럽에서 암 발병률이 증가하고 있으며, 방사선 요법은 많은 암 유형에 대한 중요한 치료 방식입니다. 인구가 계속 고령화되고 라이프스타일이 변화함에 따라 암 사례 수가 증가할 것으로 예상되어 방사선 요법에 대한 수요가 증가했습니다. 암과 치료 옵션에 대한 인식이 높아지고, 스크리닝 및 조기 발견 방법이 개선되면서 방사선 요법을 포함한 암 치료를 찾는 사람이 늘어났습니다 . 많은 국가에서 의료비 지출이 증가하여 방사선 요법과 같은 고급 치료에 대한 자금이 더 많이 지원되었습니다. 정부와 민간 의료 서비스 제공자는 시설과 장비를 업그레이드하는 데 투자해 왔습니다.
Data Bridge Market Research에 따르면 방사선 치료 시장은 2022년 21억 7,699만 달러에서 2030년 38억 9,091만 달러 규모로 성장할 것으로 예상되며, 예측 기간 동안 연평균 성장률은 7.9%일 것으로 예상됩니다.
|
보고서 메트릭 |
세부 |
|
예측 기간 |
2023년부터 2030년까지 |
|
기준 연도 |
2022 |
|
역사적 연도 |
2021 (2015-2020까지 사용자 정의 가능) |
|
양적 단위 |
수익 (단위: USD 백만) |
|
다루는 세그먼트 |
제품 및 서비스(서비스, 제품 및 소프트웨어), 유형(외부 빔 방사선 치료, 내부 방사선 치료, 전신 방사선 치료/방사성 의약품 및 기타), 응용 분야(유방암, 폐암, 전립선암, 대장암, 림프종, 간암, 갑상선암, 뇌암, 자궁경부암, 척추암 및 기타), 최종 사용자(병원, 방사선 치료 센터, 전문 병원 및 기타), 유통 채널(직접 입찰, 제3자 유통업체 및 기타) |
|
적용 국가 |
독일, 프랑스, 영국, 이탈리아, 스페인, 러시아, 터키, 벨기에, 네덜란드, 스위스, 스웨덴 및 기타 유럽 국가 |
|
시장 참여자 포함 |
Siemens Healthcare GmbH, Elekta, Accuray Incorporated, General Electric Company, IBA Worldwide, Koninklijke Philips NV, Hitachi, Ltd., CANON MEDICAL SYSTEMS CORPORATION, Nordion Inc.(Sotera Health의 자회사), Mevion Medical Systems, Eckert & Ziegler BEBIG, VIEWRAY TECHNOLOGIES, INC.(“VIEWRAY”), Brainlab, ZEISS International, BEBIG Medical., SHINVA MEDICAL INSTRUMENT CO., LTD., LinaTech, Inc., United Imaging Healthcare Co., Ltd. 등 |
시장 정의
Radiotherapy is a type of treatment procedure that is mainly used for the treatment of cancer disease by the usage of X-rays along with similar forms of radiation technology. In radiotherapy treatment, high-energy-based radiation rays are often used to damage cancer cells and stop them from growing and dividing. Various types of software such as treatment planning software, dosage planning software, patient positioning software, image guiding software, and systemic radiotherapy among others are used in radiotherapy treatment planning. The treatment software program is used to calculate the dose of radiation which will be delivered to the patient's tumor and the surrounding normal tissue.
Europe Radiotherapy Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail below:
Drivers
- Growing prevalence of cancer disease
The Europe incidence of cancer continues to rise due to factors such as aging populations, lifestyle changes, environmental factors, and increased cancer awareness and screening. The demand for effective treatment options such as radiotherapy grows as more individuals are diagnosed with cancer. Radiotherapy can be used as a primary treatment for cancer, especially in cases where surgery is not feasible or as effective. It can also be used in conjunction with surgery, chemotherapy, or immunotherapy to enhance treatment outcomes. The versatility of radiotherapy makes it an essential tool in the comprehensive cancer treatment arsenal.
Statistics on cancer describe that large groups of people have cancer across the world. Statistics show things that many people died from cancer each year. The treatment of radiotherapy can cure cancer symptoms. Radiation therapy uses high-energy particles or waves to kill the symptoms of cancer. Several people who are currently living with cancer require radiotherapy for cancer treatment. For this reason, the growing prevalence of cancer disease is acting as a driver for increasing the demand for the market.
- Novel technology in radiotherapy for cancer treatment
During the past several years, cancer radiotherapy has been largely driven by technological development. The technological development in radiotherapy is mainly focused on improving therapy procedures and launching new products which have advanced features that help in the treatment of cancer patients. This special issue aims at novel technological developments and has large potential in improving patient safety and treatment outcome in the radiotherapy management of cancers worldwide.
The modern and advanced technology-based radiotherapy procedure comprises the use of three-dimensional (3D) imaging technology, high-energy x-ray machines, and computerized treatment planning, which enhances the chances for more precise treatment possible. The increasing number of patients who successfully use radiation therapy due to technological advancement in radiotherapy and novel technology in radiotherapy for cancer treatment is expected to drive market growth.
Opportunity
- Increasing healthcare expenditure for cancer treatment
The government is continuously engaged in the activity of improving healthcare facilities to provide better health facilities and treatment to the patients such as improving cancer treatment procedures and increasing the number of radiotherapy treatment providers, among others. Growing healthcare expenditure is an opportunity for the market, because if investment in healthcare increases more people are getting aware of cancer disease and undergo advanced technology-based cancer treatment.
Continuously increasing healthcare expenditure help the end user to install the latest technology-based radiotherapy systems to improve efficiency, accuracy, and number of successful radiotherapy cancer treatments.
Restraint/Challenge
- Lack of skilled and certified professionals
Radiotherapy is a type of complex procedure, operated by highly advanced radiotherapy products which deliver radiation explorer to a targeted point of the patient body to destroy the cancer cells. The radiotherapy procedure requires highly skilled and certified professionals as in this procedure, healthcare professionals have to decide the dosages of radiation delivered to the patient's body with the help of treatment planning software. Healthcare professionals need to be aware of how to handle these software and therapy modalities. The requirement for skilled and certified professionals is a big restraint for the market. The demand for cancer treatment is increasing due to continuously increasing cases of cancer disease across the world but a lack of skilled and certified professionals hampering the growth of the market.
Recent Developments
- In June 2023, Merit Medical Systems. acquired Bluegrass Vascular’s Surfacer Inside-Out Access Catheter System. This has helped the company to generate more revenues
- In June 2023, Sonablate Corp. was recognized as one of CEO View’s top 10 healthcare companies of the year 2023. This has helped the company to establish its presence in the europe radiotherapy market
- In November 2022, Terumo Europe NV announced that it welcomed the positive guidance released by the National Institute for Health and Care Excellence (NICE), mentioning that microwave ablation can be used provided standard arrangements are in place for clinical governance, consent, and audit. This is positive news as it broadens access to minimally invasive alternatives to surgery available to patients with symptomatic benign thyroid nodules
- 2022년 7월, EDAP TMS는 CY23에 대한 CMS 외래 전향적 지불 시스템(OPPS) 제안 규칙에 따라 Focal One HIFU 환불을 비뇨기과 APC 레벨 6으로 상향 조정했다고 발표했습니다. 이를 통해 회사는 유럽에 입지를 굳건히 하는 데 도움이 되었습니다.
- 2021년 7월, Bioventus LLC.와 Misonix는 Bioventus가 Misonix를 인수하기 위한 확정적 계약을 발표했습니다. 이를 통해 회사는 제품 포트폴리오를 강화할 수 있었습니다.
유럽 방사선 치료 시장 범위
방사선 치료 시장은 제품 및 서비스, 유형, 응용 프로그램, 최종 사용자, 유통 채널 등 5가지 주요 세그먼트로 세분화됩니다. 이러한 세그먼트 간의 성장은 산업의 빈약한 성장 세그먼트를 분석하고 사용자에게 귀중한 시장 개요와 시장 통찰력을 제공하여 핵심 시장 응용 프로그램을 식별하기 위한 전략적 결정을 내리는 데 도움이 됩니다.
제품 및 서비스
- 서비스
- 제품
- 소프트웨어
제품 및 서비스를 기준으로 시장은 서비스, 제품, 소프트웨어로 세분화됩니다.
유형
- 외부 빔 방사선 치료
- 내부 방사선 치료
- 전신방사선치료/방사성의약품
- 기타
시장은 유형을 기준으로 외부 방사선 치료, 내부 방사선 치료, 전신 방사선 치료/방사성 의약품 및 기타로 구분됩니다.
애플리케이션
- 유방암
- 폐암
- 전립선암
- 대장암
- 림프종
- 간암
- 갑상선 암
- 뇌암
- 자궁경부암
- 척추암
- 기타
시장은 응용 프로그램을 기준으로 유방암, 폐암, 전립선암, 대장암, 림프종, 간암, 갑상선암, 뇌암, 자궁경부암, 척추암 등으로 구분됩니다.
최종 사용자
- 병원
- 방사선 치료 센터
- 전문 클리닉
- 기타
최종 사용자를 기준으로 시장은 병원, 방사선 치료 센터, 전문 병원 등으로 구분됩니다.
유통 채널
- 직접 입찰
- 제3자 유통업체
- 기타
유통 채널을 기준으로 시장은 직접 입찰, 제3자 유통업체 및 기타로 구분됩니다 .
유럽 방사선 치료 시장 지역 분석/통찰력
방사선 치료 시장을 분석하고, 위에 언급된 대로 국가, 제품 및 서비스, 유형, 응용 분야, 최종 사용자, 유통 채널별로 시장 규모에 대한 통찰력과 추세를 제공합니다.
이 시장 보고서에서 다루는 국가는 독일, 프랑스, 영국, 이탈리아, 스페인, 러시아, 터키, 벨기에, 네덜란드, 스위스, 스웨덴, 기타 유럽 국가입니다.
독일은 다양한 제조업체의 높은 수준의 투자와 국내 방사선 요법 수요 증가로 인해 시장을 지배할 것으로 예상됩니다.
보고서의 국가 섹션은 또한 현재 및 미래 시장 추세에 영향을 미치는 개별 시장 영향 요인과 시장 규제의 변화를 제공합니다. 하류 및 상류 가치 사슬 분석, 기술 추세, 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 지역 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세의 영향 및 무역 경로가 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.
경쟁 환경 및 유럽 방사선 치료 시장 점유율 분석
방사선 치료 시장 경쟁 구도는 경쟁자에 대한 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 새로운 시장 이니셔티브, 지역적 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.
방사선 치료 시장에서 활동하는 주요 기업으로는 Siemens Healthcare GmbH, Elekta, Accuray Incorporated, General Electric Company, IBA Worldwide, Koninklijke Philips NV, Hitachi, Ltd., CANON MEDICAL SYSTEMS CORPORATION, Nordion Inc.(Sotera Health의 자회사), Mevion Medical Systems, Eckert & Ziegler BEBIG, VIEWRAY TECHNOLOGIES, INC.("VIEWRAY"), Brainlab, ZEISS International, BEBIG Medical., SHINVA MEDICAL INSTRUMENT CO., LTD., LinaTech, Inc., United Imaging Healthcare Co., Ltd. 등이 있습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE RADIOTHERAPY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT AND SERVICES SEGMENT LIFELINE CURVE
2.8 MARKET END USERS COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES MODEL
5 REGULATORY GUIDELINES FOR RADIOTHERAPY
5.1 EUROPE REGULATORY GUIDELINE FOR RADIOTHERAPY
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 GROWING PREVALENCE OF CANCER DISEASE
6.1.2 NOVEL TECHNOLOGY IN RADIOTHERAPY FOR CANCER TREATMENT
6.1.3 INCREASING ADOPTION OF RADIOTHERAPY DEVICES AND PROCEDURES
6.1.4 RISING PREFERENCE FOR NON-SURGICAL PROCEDURES
6.2 RESTRAINTS
6.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
6.2.2 HIGH COST OF TREATMENT AND RADIOTHERAPY PROCEDURE
6.3 OPPORTUNITIES
6.3.1 INCREASING HEALTHCARE EXPENDITURE FOR CANCER TREATMENT
6.3.2 GROWING GOVERNMENT INITIATIVES TOWARD CANCER TREATMENT
6.3.3 RISING PATIENTS AWARENESS TOWARDS CANCER TREATMENT
6.4 CHALLENGES
6.4.1 STRICT REGULATIONS AND STANDARDS FOR APPROVAL AND COMMERCIALIZATION OF RADIOTHERAPY PRODUCTS
6.4.2 RISK OF RADIATION EXPOSURE
7 EUROPE RADIOTHERAPY MARKET, BY PRODUCT & SERVICES
7.1 OVERVIEW
7.2 SERVICES
7.3 PRODUCT
7.3.1 EXTERNAL BEAM RADIOTHERAPY
7.3.1.1 LINAC
7.3.1.2 PROTON THERAPY
7.3.1.2.1 SYNCHROTRON
7.3.1.2.2 CYCLOTRON
7.3.1.3 CYBER KNIFE
7.3.1.4 GAMMA KNIFE
7.3.1.5 OTHERS
7.3.2 INTERNAL RADIATION RADIOTHERAPY
7.3.2.1 SEEDS
7.3.2.2 ELECTRONIC BRACHYTHERAPY
7.3.2.3 APPLICATORS
7.3.2.4 AFTERLOADERS
7.3.2.5 OTHERS
7.3.3 SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS
7.3.3.1 ALPHA EMITTERS
7.3.3.2 BETA EMITTERS
7.3.3.3 OTHERS
7.4 SOFTWARE
7.4.1 IMAGE GUIDING SOFTWARE
7.4.2 TREATMENT PLANNING SOFTWARE
7.4.3 PATIENT POSITIONING SOFTWARE
7.4.4 DOSAGE PLANNING SOFTWARE
7.4.5 OTHERS
8 EUROPE RADIOTHERAPY MARKET, BY TYPE
8.1 OVERVIEW
8.2 EXTERNAL-BEAM RADIATION THERAPY
8.2.1 IMAGE-GUIDED RADIATION THERAPY (IGRT)
8.2.2 PROTON BEAM THERAPY
8.2.3 STEREOTACTIC RADIATION THERAPY
8.2.4 INTENSITY MODULATED RADIATION THERAPY (IMRT)
8.2.5 THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY (3D-CRT)
8.2.6 VOLUMETRIC MODULATED ARC THERAPY (VMAT)
8.2.7 OTHERS
8.3 INTERNAL RADIATION THERAPY
8.3.1 BRACHYTHERAPY
8.3.2 INTRAOPERATIVE RADIATION THERAPY (IORT)
8.3.3 OTHERS
8.4 SYSTEMIC RADIOTHERAPY/ RADIOPHARMACEUTICALS
8.5 OTHERS
9 EUROPE RADIOTHERAPY MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 BREAST CANCER
9.3 LUNG CANCER
9.4 PROSTATE CANCER
9.5 COLORECTAL CANCER
9.6 LYMPHOMA
9.7 LIVER CANCER
9.8 THYROID CANCER
9.9 BRAIN CANCER
9.1 CERVICAL CANCER
9.11 SPINE CANCER
9.12 OTHERS
10 EUROPE RADIOTHERAPY MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 RADIATION THERAPY CENTERS
10.4 SPECIALTY CLINICS
10.5 OTHERS
11 EUROPE RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDERS
11.3 THIRD PARTY DISTRIBUTORS
11.4 OTHERS
12 EUROPE RADIOTHERAPY MARKET, BY COUNTRY
12.1 GERMANY
12.2 FRANCE
12.3 U.K.
12.4 ITALY
12.5 SPAIN
12.6 RUSSIA
12.7 TURKEY
12.8 BELGIUM
12.9 NETHERLANDS
12.1 SWITZERLAND
12.11 SWEDEN
12.12 REST OF EUROPE
13 EUROPE RADIOTHERAPY MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: EUROPE
14 SWOT ANALYSIS
15 COMPANY PROFILES
15.1 ELEKTA
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 PRODUCT PORTFOLIO
15.1.4 RECENT DEVELOPMENTS
15.2 GENERAL ELECTRIC COMPANY
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 PRODUCT PORTFOLIO
15.2.4 RECENT DEVELOPMENT
15.3 SIEMENS HEALTHCARE GMBH
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT DEVELOPMENT
15.4 HITACHI, LTD.
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 PRODUCT PORTFOLIO
15.4.4 RECENT DEVELOPMENT
15.5 KONINKLIJKE PHILIPS N.V.
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENT
15.6 ACCURACY INCORPORATED
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENT
15.7 BEBIG MEDICAL.
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENT
15.8 BRAINLAB
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENTS
15.9 CANON MEDICAL SYSTEMS CORPORATION
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.9.4 RECENT DEVELOPMENT
15.1 ECKERT & ZIEGLER BEBIG
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENT
15.11 IBA WORLDWIDE
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENT
15.12 LINATECH INC
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENT
15.13 MEVION MEDICAL SYSTEMS
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 NORDION (CANADA) INC. (A SUBSIDIARY OF SOTERA HEALTH)
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 SHINVA MEDICAL INSTRUMENT CO., LTD.
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 UNITED IMAGING HEALTHCARE CO., LTD
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 VIEWRAY TECHNOLOGIES, INC. (“VIEWRAY”)
15.17.1 COMPANY SNAPSHOT
15.17.2 REVENUE ANALYSIS
15.17.3 PRODUCT PORTFOLIO
15.17.4 RECENT DEVELOPMENT
15.18 ZEISS INTERNATIONAL
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 PRODUCT PORTFOLIO
15.18.4 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
표 목록
TABLE 1 EUROPE RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 2 EUROPE PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 3 EUROPE EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 4 EUROPE PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 5 EUROPE INTERNAL RADIATION RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 6 EUROPE SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 7 EUROPE SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 8 EUROPE RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 9 EUROPE EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 10 EUROPE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 11 EUROPE RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 12 EUROPE RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 13 EUROPE RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 14 EUROPE RADIOTHERAPY MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 15 GERMANY RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 16 GERMANY PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 17 GERMANY EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 18 GERMANY PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 19 GERMANY INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 20 GERMANY SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 21 GERMANY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 22 GERMANY RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 23 GERMANY EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 24 GERMANY INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 25 GERMANY RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 26 GERMANY RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 27 GERMANY RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 28 FRANCE RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 29 FRANCE PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 30 FRANCE EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 31 FRANCE PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 32 FRANCE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 33 FRANCE SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 34 FRANCE SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 35 FRANCE RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 36 FRANCE EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 37 FRANCE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 38 FRANCE RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 39 FRANCE RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 40 FRANCE RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 41 U.K. RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 42 U.K. PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 43 U.K. EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 44 U.K. PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 45 U.K. INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 46 U.K. SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 47 U.K. SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 48 U.K. RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 49 U.K. EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 50 U.K. INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 51 U.K. RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 52 U.K. RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 53 U.K. RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 54 ITALY RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 55 ITALY PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 56 ITALY EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 57 ITALY PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 58 ITALY INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 59 ITALY SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 60 ITALY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 61 ITALY RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 62 ITALY EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 63 ITALY INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 64 ITALY INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 65 ITALY RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 66 ITALY RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 67 SPAIN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 68 SPAIN PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 69 SPAIN EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 70 SPAIN PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 71 SPAIN INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 72 SPAIN SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 73 SPAIN SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 74 SPAIN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 75 SPAIN EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 76 SPAIN INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 77 SPAIN RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 78 SPAIN RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 79 SPAIN RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 80 RUSSIA RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 81 RUSSIA PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 82 RUSSIA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 83 RUSSIA PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 84 RUSSIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 85 RUSSIA SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 86 RUSSIA SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 87 RUSSIA RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 88 RUSSIA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 89 RUSSIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 90 RUSSIA RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 91 RUSSIA RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 92 RUSSIA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 93 TURKEY RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 94 TURKEY PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 95 TURKEY EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 96 TURKEY PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 97 TURKEY INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 98 TURKEY SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 99 TURKEY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 100 TURKEY RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 101 TURKEY EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 102 TURKEY INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 103 TURKEY RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 104 TURKEY RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 105 TURKEY RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 106 BELGIUM RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 107 BELGIUM PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 108 BELGIUM EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 109 BELGIUM PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 110 BELGIUM INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 111 BELGIUM SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 112 BELGIUM SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 113 BELGIUM RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 114 BELGIUM EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 115 BELGIUM INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 116 BELGIUM RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 117 BELGIUM RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 118 BELGIUM RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 119 NETHERLANDS RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 120 NETHERLANDS PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 121 NETHERLANDS EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 122 NETHERLANDS PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 123 NETHERLANDS INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 124 NETHERLANDS SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 125 NETHERLANDS SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 126 NETHERLANDS RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 127 NETHERLANDS EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 128 NETHERLANDS INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 129 NETHERLANDS EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 130 NETHERLANDS RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 131 NETHERLANDS RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 132 SWITZERLAND RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 133 SWITZERLAND PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 134 SWITZERLAND EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 135 SWITZERLAND PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 136 SWITZERLAND INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 137 SWITZERLAND SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 138 SWITZERLAND SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 139 SWITZERLAND RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 140 SWITZERLAND EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 141 SWITZERLAND INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 142 SWITZERLAND RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 143 SWITZERLAND RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 144 SWITZERLAND RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 145 SWEDEN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 146 SWEDEN PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 147 SWEDEN EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 148 SWEDEN PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 149 SWEDEN INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 150 SWEDEN SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 151 SWEDEN SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 152 SWEDEN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 153 SWEDEN EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 154 SWEDEN INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 155 SWEDEN RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 156 SWEDEN RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 157 SWEDEN RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 158 REST OF EUROPE RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
그림 목록
FIGURE 1 EUROPE RADIOTHERAPY MARKET: SEGMENTATION
FIGURE 2 EUROPE RADIOTHERAPY MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE RADIOTHERAPY MARKET: DROC ANALYSIS
FIGURE 4 EUROPE RADIOTHERAPY MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE RADIOTHERAPY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE RADIOTHERAPY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE RADIOTHERAPY MARKET: MARKET END USERS COVERAGE GRID
FIGURE 8 EUROPE RADIOTHERAPY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE RADIOTHERAPY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE RADIOTHERAPY MARKET: SEGMENTATION
FIGURE 11 THE RISING PREVALENCE OF CANCER AND GROWING DEMAND FOR MINIMALLY INVASIVE PROCEDURES ARE EXPECTED TO DRIVE THE GROWTH OF THE EUROPE RADIOTHERAPY MARKET FROM 2023 TO 2030
FIGURE 12 THE PRODUCT AND SERVICES SEGMENT, IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE RADIOTHERAPY MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITY AND CHALLENGES FOR EUROPE RADIOTHERAPY MARKET
FIGURE 14 EUROPE RADIOTHERAPY MARKET: BY PRODUCT & SERVICES, 2022
FIGURE 15 EUROPE RADIOTHERAPY MARKET: BY PRODUCT & SERVICES, 2023-2030 (USD MILLION)
FIGURE 16 EUROPE RADIOTHERAPY MARKET: BY PRODUCT & SERVICES, CAGR (2023-2030)
FIGURE 17 EUROPE RADIOTHERAPY MARKET: BY PRODUCT & SERVICES, LIFELINE CURVE
FIGURE 18 EUROPE RADIOTHERAPY MARKET: BY TYPE, 2022
FIGURE 19 EUROPE RADIOTHERAPY MARKET: BY TYPE, 2023-2030 (USD MILLION)
FIGURE 20 EUROPE RADIOTHERAPY MARKET: BY TYPE, CAGR (2023-2030)
FIGURE 21 EUROPE RADIOTHERAPY MARKET: BY TYPE, LIFELINE CURVE
FIGURE 22 EUROPE RADIOTHERAPY MARKET: BY APPLICATION, 2022
FIGURE 23 EUROPE RADIOTHERAPY MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 24 EUROPE RADIOTHERAPY MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 25 EUROPE RADIOTHERAPY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 EUROPE RADIOTHERAPY MARKET: BY END USER, 2022
FIGURE 27 EUROPE RADIOTHERAPY MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 EUROPE RADIOTHERAPY MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 EUROPE RADIOTHERAPY MARKET: BY END USER LIFELINE CURVE
FIGURE 30 EUROPE RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 EUROPE RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 EUROPE RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 EUROPE RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 EUROPE RADIOTHERAPY MARKET: SNAPSHOT (2022)
FIGURE 35 Europe Radiotherapy Market: Company Share 2022 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
